Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aruchuna Ruban

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of the Endocrine Society|December 11, 2024
Satiety Hormone LEAP2 After Low-Calorie Diet With/Without Endobarrier Insertion in Obesity and Type 2 Diabetes MellitusMimoza Emini, Raghav Bhargava, Madhawi Aldhwayan, et al.
Clinical Nutrition (Edinburgh, Scotland)|November 2, 2020
The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acidsMichael A Glaysher, James Ward, Madhawi Aldhwayan, et al.
Annals of Surgery|October 14, 2021
Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled TrialAruchuna Ruban, Alexander D Miras, Michael A Glaysher, et al.
Diabetes Care|January 30, 2023
Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated WorldwideRobert E J Ryder, Katharina Laubner, Marek Benes, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of the Endocrine Society|December 11, 2024
Satiety Hormone LEAP2 After Low-Calorie Diet With/Without Endobarrier Insertion in Obesity and Type 2 Diabetes MellitusMimoza Emini, Raghav Bhargava, Madhawi Aldhwayan, et al.
Clinical Nutrition (Edinburgh, Scotland)|November 2, 2020
The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acidsMichael A Glaysher, James Ward, Madhawi Aldhwayan, et al.
Annals of Surgery|October 14, 2021
Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled TrialAruchuna Ruban, Alexander D Miras, Michael A Glaysher, et al.
Diabetes Care|January 30, 2023
Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated WorldwideRobert E J Ryder, Katharina Laubner, Marek Benes, et al.
Pageof 2